Cargando…
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) is mechanistically and therapeutically challenging, not only because of the molecular and cellular perturbations that generate vascular abnormalities, but also the modifications to circulatory physiology that result, and are likely to exacerbate vascular i...
Autor principal: | Shovlin, Claire L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391027/ https://www.ncbi.nlm.nih.gov/pubmed/25914716 http://dx.doi.org/10.3389/fgene.2015.00101 |
Ejemplares similares
-
Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
por: Ardelean, Daniela S., et al.
Publicado: (2015) -
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019) -
Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era
por: McDonald, Jamie, et al.
Publicado: (2015) -
A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report
por: Khan, Ahmad R., et al.
Publicado: (2022) -
Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency
por: Finnamore, Helen, et al.
Publicado: (2013)